IRAK4-IN-20 (Compound BAY-1834845) is an orally active IRAK4 inhibitor with an IC50 of 3.55 nM. IRAK4-IN-20 can be used for acute respiratory distress syndrome (ARDS) research[1].
Molecular Weight:
450.45
Purity:
97.04
CAS Number:
[1931994-80-7]
Formula:
C22H25F3N4O3
Target:
IRAK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted